A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
出版年份 2012 全文链接
标题
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
作者
关键词
-
出版物
Science Translational Medicine
Volume 4, Issue 137, Pages 137ra75-137ra75
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2012-06-07
DOI
10.1126/scitranslmed.3003643
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
- (2012) Xun Xu et al. CELL
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
- (2011) J S P Yuen et al. BRITISH JOURNAL OF CANCER
- Integrative Genomic Analyses of Sporadic Clear Cell Renal Cell Carcinoma Define Disease Subtypes and Potential New Therapeutic Targets
- (2011) V. R. Dondeti et al. CANCER RESEARCH
- A Blueprint for Advancing Genetics-Based Cancer Therapy
- (2011) William R. Sellers CELL
- Regulation of TFEB and V-ATPases by mTORC1
- (2011) Samuel Peña-Llopis et al. EMBO JOURNAL
- Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients
- (2011) Chiara Grisanzio et al. JOURNAL OF PATHOLOGY
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma
- (2011) B. Kucejova et al. MOLECULAR CANCER RESEARCH
- Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC
- (2011) Toshinari Yamasaki et al. Nature Reviews Urology
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death
- (2011) B Kucejova et al. ONCOGENE
- The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases
- (2010) Tamer Abou Youssif et al. CANCER
- Development and Characterization of Clinically Relevant Tumor Models From Patients With Renal Cell Carcinoma
- (2010) Jose A. Karam et al. EUROPEAN UROLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Preclinical development of molecular-targeted agents for cancer
- (2010) Alberto Ocana et al. Nature Reviews Clinical Oncology
- Anticancer drug development: the grand challenges
- (2010) William N. Hait NATURE REVIEWS DRUG DISCOVERY
- Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays
- (2009) Meng Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
- (2008) M. L. Nickerson et al. CLINICAL CANCER RESEARCH
- Sirolimus in Metatastic Renal Cell Carcinoma
- (2008) James Brugarolas et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics
- (2007) Ahmad Awada et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started